chloramphenicol has been researched along with quinupristin-dalfopristin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindmark, A; Nord, CE; Persson, I | 1 |
| Bradley, JS; Scheld, WM | 1 |
| Deobaldia, J; Evans, PA; Norden, CW; Rhoads, S; Silber, JL | 1 |
| Messick, CR; Pendland, SL | 1 |
| Ackerman, BH; Cawley, MJ; Guilday, RJ; Haith, LR; Patton, ML; Reilly, KJ; Rose, CM | 1 |
| Athamna, A; Athamna, M; Bast, DJ; Medlej, B; Rubinstein, E | 1 |
1 review(s) available for chloramphenicol and quinupristin-dalfopristin
| Article | Year |
|---|---|
The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Chloramphenicol; Clindamycin; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Lactams; Male; Meningitis, Bacterial; Naphthyridines; Penicillin Resistance; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1997 |
5 other study(ies) available for chloramphenicol and quinupristin-dalfopristin
| Article | Year |
|---|---|
Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefoxitin; Chloramphenicol; Clostridium perfringens; Imipenem; Microbial Sensitivity Tests; Piperacillin; Species Specificity; Virginiamycin | 1989 |
In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
Emergence of resistance of vancomycin-resistant Enterococcus faecium in a thermal injury patient treated with quinupristin-dalfopristin and cultured epithelial autografts for wound closure.
Topics: Adult; Burns; Chloramphenicol; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Graft Survival; Gram-Positive Bacterial Infections; Humans; Male; Skin Transplantation; Vancomycin Resistance; Virginiamycin | 2002 |
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Topics: Acetamides; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactams; Chloramphenicol; Clindamycin; Fluoroquinolones; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Tetracyclines; Vancomycin; Virginiamycin | 2004 |